Lung Cancer Trials Ask AI to find trials
CompletedNot applicableNCT03746392
Official study title

Project to Improve Communication About Serious Illness - Pilot Study

Study summary

This two-year pilot study will test whether a one-page "Jumpstart Form" will affect goals-of-care discussions in the hospital. This form will be provided to clinicians and will include patient-specific information about preferences for goals-of-care communication and for care, as well as tips to improve this communication. Jumpstart forms will also be provided to patients or, if they are unable to communicate, their surrogates/family members. The information on the form will be obtained from questionnaires. The form is tailored to help patients and surrogates talk with clinicians about goals of care. This study is based on a successful application of Jumpstart Form in the outpatient clinic setting.

Ask AI to explain this study
Start here

Key things to know

Main goalSupportive Care

This describes the study’s primary purpose.

What is being studiedJumpstart Intervention

The study team can explain what participation involves.

Who it may be forMalignant Neoplasm · Leukemia, Lymphocytic, Chronic, B-Cell

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Aug 22, 2025 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?2 U.S. locations

Locations may change over time.

Who runs it?University of Washington

Study sponsor

01
Study overview

What this study is about

Purpose
Supportive Care
Study type
Interventional
Phase
Not applicable
Sponsor
University of Washington
Interventions being studied
Behavioral: Jumpstart Intervention
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach
Supportive or behavioral care→
03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • , Patients: meeting criteria for serious illness (encompassing multiple acute and chronic illnesses) including:
  • those used by the Dartmouth Atlas to study end-of-life care in the US: malignant cancer/leukemia, chronic pulmonary disease, coronary artery disease, congestive heart failure, chronic liver disease, chronic renal disease, dementia, diabetes with end-organ damage, and peripheral vascular disease.
  • patients over age 65 with markers of frailty: albumin level \<3.0 within 48 hours of admission and weight loss of ≥10 pounds in the past year.
  • hospitalized patients over age 80.
  • English-speaking
Reasons someone may not be able to joinExclusion criteria
  • , Patients:
  • unable to complete informed consent procedures and do not have a legal next of kin
  • restricted information status (e.g. prisoners)
  • pregnant Inclusion Criteria, Surrogates:
  • involved in the care of an eligible patient as the legal next-of-kin
  • English-speaking

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Harborview Medical CenterSeattle, Washington
  • University of Washington Medical CenterSeattle, Washington

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 22, 2025. Always confirm current availability with the study team.

View original record ↗